Literature DB >> 1373734

Direct evidence for increased continuous histamine release in the striatum of conscious freely moving rats produced by middle cerebral artery occlusion.

N Adachi1, Y Itoh, R Oishi, K Saeki.   

Abstract

Extracellular histamine in the stratum of conscious freely moving rats collected by intracerebral microdialysis 1 day after implantation of a U-shaped dialysis probe was measured by HPLC coupled with postcolumn o-phthalaldehyde derivatization fluorometry. The basal fractional histamine outputs were almost constant from 1 to 7 h after the start of perfusion (5.9-8.4 pg/30 min). Depolarization by perfusion with a high K+ (100 mM)-containing medium produced a significant (124%) increase and neuronal blockade by perfusion with a tetrodotoxin (1 microM)-containing medium resulted in a 68% reduction in the histamine output. The histamine output was markedly reduced by intraperitoneal injection of alpha-fluoromethylhistidine (100 mg/kg), an irreversible inhibitor of histidine decarboxylase, or (R)-alpha-methylhistamine (5 mg/kg), a potent and specific H3-receptor agonist. After middle cerebral artery (MCA) occlusion, the histamine output gradually increased, and reached four times the control value 8 h later. When rats were pretreated with metoprine (10 mg/kg), a histamine N-methyltransferase inhibitor, there was no significant difference in the histamine output between the MCA-occluded and the sham-operated groups during the first 3.5 h after the operation, but the histamine output gradually increased thereafter in the MCA-occluded group. In rats treated with alpha-fluoromethylhistidine, MCA occlusion failed to cause an increase in the histamine output. These results demonstrate that MCA occlusion induces a long-lasting increase in neuronal histamine release in the rat striatum.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373734     DOI: 10.1038/jcbfm.1992.65

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  7 in total

1.  Evaluation of a Portable Microchip Electrophoresis Fluorescence Detection System for the Analysis of Amino Acid Neurotransmitters in Brain Dialysis Samples.

Authors:  Nathan J Oborny; Elton E Melo Costa; Leena Suntornsuk; Fabiane C Abreu; Susan M Lunte
Journal:  Anal Sci       Date:  2016       Impact factor: 2.081

Review 2.  Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives.

Authors:  M Bhowmik; R Khanam; D Vohora
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

3.  Nicotine Exposure Along with Oral Contraceptive Treatment in Female Rats Exacerbates Post-cerebral Ischemic Hypoperfusion Potentially via Altered Histamine Metabolism.

Authors:  Nathan d'Adesky; Francisca Diaz; Weizhao Zhao; Helen M Bramlett; Miguel A Perez-Pinzon; Kunjan R Dave; Ami P Raval
Journal:  Transl Stroke Res       Date:  2020-11-01       Impact factor: 6.829

Review 4.  Role of histamine and its receptors in cerebral ischemia.

Authors:  Wei-Wei Hu; Zhong Chen
Journal:  ACS Chem Neurosci       Date:  2012-02-10       Impact factor: 4.418

5.  Regulation of K+ conductance by histamine H1 and H2 receptors in neurones dissociated from rat neostriatum.

Authors:  M Munakata; N Akaike
Journal:  J Physiol       Date:  1994-10-15       Impact factor: 5.182

6.  Targeted disruption of organic cation transporter 3 (Oct3) ameliorates ischemic brain damage through modulating histamine and regulatory T cells.

Authors:  Pengxiang Zhu; Ryuji Hata; Masahito Ogasawara; Fang Cao; Kenji Kameda; Kohei Yamauchi; Alfred H Schinkel; Kazutaka Maeyama; Masahiro Sakanaka
Journal:  J Cereb Blood Flow Metab       Date:  2012-06-27       Impact factor: 6.200

Review 7.  Histamine and the striatum.

Authors:  J Paul Bolam; Tommas J Ellender
Journal:  Neuropharmacology       Date:  2015-08-11       Impact factor: 5.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.